Latest KFF Health News Stories
Dialysis Industry Spends Big To Protect Profits
Dialysis companies are fighting a bill in the California legislature that could disrupt their business model. Their weapons: campaign cash and a sophisticated public relations campaign.
KHN’s ‘What The Health?’: All About Medicare
Before “Medicare for All,” there was just Medicare, the federal program that provides insurance to 60 million Americans. This week, KHN’s Julie Rovner talks to Tricia Neuman of the Kaiser Family Foundation about how Medicare works and whom it serves. Then, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Kimberly Leonard of the Washington Examiner join Rovner to talk about some current Medicare issues being debated in Washington, D.C.
Feds Pave The Way To Expand Home Dialysis — But Patients Hit Roadblocks
What changes are needed to bring home dialysis to more patients — especially older adults, the fastest-growing group of patients with serious, irreversible kidney disease? We asked nephrologists, patient advocates and dialysis company officials for their thoughts.
Shopping Abroad For Cheaper Medication? Here’s What You Need To Know
Americans routinely skirt federal law by crossing into Canada and Mexico or tapping online pharmacies abroad to purchase prescription medications at a fraction of the price they would pay at home. Is it safe? Not necessarily. Here’s some advice.
Joe Camel Was Forced Out Of Ads. So Why Is Juul Allowed On TV?
For nearly 50 years, cigarette advertising has been banned from TV and radio. But the marketing of electronic cigarettes isn’t constrained by that law.
MDMA, Or Ecstasy, Shows Promise As A PTSD Treatment
MDMA, the psychoactive ingredient in the club drug known as molly or ecstasy, is being tested in combination with therapy as a treatment for severe trauma.
The Collapse Of A Hospital Empire — And Towns Left In The Wreckage
Jorge A. Perez and his management company, EmpowerHMS, helped run an empire of rural hospitals. Now, in a staggering implosion, 12 of them have entered bankruptcy and eight have closed their doors, leaving hundreds of residents without jobs and their communities without lifesaving emergency medical care. So, what happened?
A Brush With A Notorious Cat, My Rabies Education And The Big Bill That Followed
An encounter with a cat led to rabies shots and provided yet another illustration of how confusing, contrary and expensive the American health care system is.
After A Rural Hospital Closes, Delays In Emergency Care Cost Patients Dearly
The loss of the longtime hospital in Fort Scott, Kan., forces trauma patients to deal with changing services and expectations.
DIY Tech Gives People More Freedom In Managing Diabetes
People with diabetes say they’ve been waiting for years for better technology to manage their chronic condition. Tired of waiting, some tech-savvy, do-it-yourselfers are constructing their own devices using open-source programming instructions.
Despite Failed Promises, Stem Cell Advocates Again Want Taxpayers To Pony Up Billions
California’s stem cell agency, created by a $3 billion bond measure 15 years ago, is almost out of money. Its supporters plan to ask voters for even more funding next year, even though no agency-funded treatments have been approved for widespread use.
Health Plan’s ‘Cadillac Tax’ May Finally Be Running Out Of Gas
The tax on generous health plans — originally envisioned as a way to help pay for the ACA and change consumers’ behavior — has never been implemented, and Congress is considering repeal.
What The Trump Home Dialysis Plan Would Really Look Like
It takes more than an executive order to shift kidney disease patients from dialysis centers to home care. These patients show it takes discipline, skill, will and support.
Among Hurdles For Those With Opioid Addictions: Getting The Drug To Treat It
It can be difficult to get a prescription for buprenorphine, one of the gold standards for treating opioid use disorder. And not all pharmacies stock the drug.
KHN’s ‘What The Health?’: We Answer Your Questions
You asked about drug prices, the “Cadillac tax” on generous insurance plans and why Americans don’t know that most other countries also have combination public-private insurance systems. This week, Anna Edney of Bloomberg News, Alice Miranda Ollstein of Politico and Caitlin Owens of Axios join KHN’s Julie Rovner to answer those questions.
Watch: Defining The Debate On Health Care Coverage Options
Politicians are throwing around a lot of terms when they talk about their health care plans: universal care, “Medicare for All,” “Medicare Buy-In.” KHN helps explain what they are talking about.
Going Down Fighting: Dying Activist Champions ‘Medicare For All’
Presidential hopeful Elizabeth Warren tried to tell the story of Ady Barkan in the latest Democratic debate. He’s one of the most prominent advocates for “Medicare for All” and is spending his remaining time alive doing everything he can to make the case that all Americans need affordable health coverage.
Doctors Can Change Opioid Prescribing Habits, But Progress Comes In Small Doses
Research out Wednesday indicates that guidelines are making strides in cutting back the number of pain pills doctors offer after specific types of surgeries.
Trump Administration Hits Brakes On Law To Curb Unneeded Medicare CT Scans, MRIs
Critics worry the delays come at a steep cost: Medicare paying for millions of unnecessary exams and patients subject to radiation for no medical benefit.
As States Strive To Stabilize Insurance Marketplaces, Insurers Return
States increasingly expect to see insurers enter or re-enter ACA marketplaces next year. That’s a critical sign that these exchanges are growing less risky for insurers despite ongoing political and legal battles over the ACA.
